Cargando…

Clinical outcomes associated with once daily ritonavir-boosted darunavir in HIV infected patients harboring single or multi-class resistant virus

BACKGROUND: Limited data exist on the use of a potent boosted protease inhibitor plus <2 active nucleotide reverse transcriptase inhibitors without use of additional classes of ART in treatment experienced patients with background resistance. We evaluated the clinical outcomes in HIV-infected pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Duggan, Joan, Sahloff, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630885/
http://dx.doi.org/10.1093/ofid/ofx163.1092

Ejemplares similares